Ultrasound-guided percutaneous radiofrequency ablation in treatment of liver metastases of malignant tumor
10.13929/j.1672-8475.201708002
- VernacularTitle:超声引导下经皮射频消融治疗恶性肿瘤肝转移
- Author:
Shuzhi LIN
1
;
Qian XU
;
Jinyu WU
;
Kun YAN
;
Wei WU
Author Information
1. 哈尔滨市第一医院超声科
- Keywords:
Ultrasonography;
Catheter ablation;
Liver;
Neoplasm metastasis
- From:
Chinese Journal of Interventional Imaging and Therapy
2018;15(1):29-32
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the application value of ultrasound-guided percutaneous radiofrequency ablation (RFA) in treatment of liver metastases of malignant tumor.Methods Clinical and imaging data of 109 patients with liver metastases of malignant tumor who underwent ultrasound-guided percutaneous RFA during December 2009 to May 2015 were retrospectively analyzed.Results There were 31 patients (31/109,28.44％) with single liver metastases and 78 patients (78/109,71.56％) with multiple lesions.The primary tumors included colorectal,lung,breast,gastric,pancreatic,ovarian and prostate carcinomas.Among all 198 liver metastases,there were 151 (151/198,76.26％) with diameter ＜ 3 cm and 47 (47/198,23.74％) with diameter ≥3 cm.One month after RFA,187 lesions (187/198,94.44％) were completely inactivated,while the other 11 lesions (11/198,5.56％) still had residual activity.One month later,the tumor markers improved obviously compared with those before treatment (all P＜0.05).The incidence of intraoperative and postoperative complications was 6.42％ (7/109).Conclusion Ultrasound-guided percutaneous RFA is a safe and effective treatment for patients with non-surgical indications of malignant liver metastases,which can partially control the survival activity of liver metastases.
